Zentiva’s capitalization, mainly known for manufacturing Antinevralgic and Dicarbocalm drugs, decreased by 23 million lei, at RON742 million since September 1.
Zentiva currently has a 0.5% share in BET-XT and BET-XT-TR, and 0.99% in BET-BK. The decision to exit the three indices comes on the company’s liquidity decreasing at RON5.69 million during the first eight months of the year, compared with RON8.6 million during the same period a year before.
(English version by Manuela Panescu)